Főoldal / Kutatás / Peking University Sixth Hospital Intézmény
Peking University Sixth Hospital Más néven: School of Mental Health, Peking University
13 futó vizsgálat 14 lezárt vizsgálat 3410 publikáció (OpenAlex) Futó vizsgálatok Még nem toboroz
A Study to Evaluate the Long-term Safety of HS-10380 in Patients With Schizophrenia
NCT07759869 · 3. fázis · Jiangsu Hansoh Pharmaceutical Co., Ltd. · Forrás
Toboroz
Identification and Molecular Characterisation of Urban-environmental Stress Patterns Affecting Mental Illness
NCT07571226 · Huashan Hospital · Forrás
Toboroz
Efficacy of Bright Light Therapy on Cognitive Impairment in Major Depressive Disorder and Its Neuroimaging Mechanisms: Protocol for a Randomised Controlled Trial
NCT07508215 · Peking University Sixth Hospital · Forrás
Toboroz
A Study of Brenipatide in Adult Participants With Major Depressive Disorder
NCT07412756 · 3. fázis · Eli Lilly and Company · Forrás
Fut, nem toboroz
A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
NCT07169578 · 3. fázis · Hoffmann-La Roche · Forrás
Toboroz
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
NCT07011732 · 3. fázis · Bristol-Myers Squibb · Forrás
Toboroz
pBFS Guided aiTBS Over Language Network for ASD Child
NCT06950437 · Beijing Changping Tianhe Research Institute of Brain Science · Forrás
Toboroz
Clinical Efficacy, Safety, and Applicability of Home-based Bright Light Therapy in Outpatient Adolescents With Major Depressive Disorder
NCT06913309 · Peking University Sixth Hospital · Forrás
Toboroz
Evaluate the Efficacy and Safety of TTYP01 Tablets in Adolescents and Children With ASD
NCT06757504 · 2. fázis · Shanghai Auzone Biological Technology Co., Ltd. · Forrás
Még nem toboroz
An Exploratory Clinical Study of a Low-dose Buprenorphine Patch for the Treatment of Autism Spectrum Disorders
NCT06772324 · Peking University Sixth Hospital · Forrás
Fut, nem toboroz
Phase 3, Double-blind, Randomized, Placebo-controlled Trial to Evaluate the Efficacy and Safety of AR1001 in Participants With Early Alzheimer's Disease (Polaris-AD)
NCT05531526 · 3. fázis · AriBio Co., Ltd. · Forrás
Fut, nem toboroz
A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)
NCT05508789 · 3. fázis · Eli Lilly and Company · Forrás
Toboroz
Study on the Mechanism of Eating Disorder
NCT05862389 · Peking University · Forrás
Egyszerre toboroz Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.
Lezárt vizsgálatok Lezárult
The Research of Ammoxetine Hydrochloride Enteric-coated Tablets in Subjects With Depression
NCT06827431 · 3. fázis · CSPC ZhongQi Pharmaceutical Technology Co., Ltd. · Forrás
Lezárult
A Study to Evaluate the Efficacy, Safety and Tolerability of Oral AK0901 in Children With ADHD
NCT06359899 · 3. fázis · Shanghai Ark Biopharmaceutical Co., Ltd. · Forrás
Lezárult
A Study of the Safety and Efficacy of Pimavanserin in Patients With Parkinson's Disease Psychosis
NCT06068465 · 3. fázis · Tasly Pharmaceutical Group Co., Ltd · Forrás
Lezárult
A Study of Daridorexant in Chinese Patients With Insomnia Disorder
NCT06010693 · 3. fázis · Jiangsu Simcere Pharmaceutical Co., Ltd. · Forrás
Lezárult
A Study to Evaluate Efficacy and Safety of Toludesvenlafaxine Hydrochloride Sustained-release Tablets in Generalized Anxiety Disorder.
NCT05970510 · 3. fázis · Luye Pharma Group Ltd. · Forrás
Lezárult
A Twelve-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of Solriamfetol in the Treatment of Excessive Daytime Sleepiness (EDS) in Patients with Obstructive Sleep Apnea (OSA)
NCT06103825 · 3. fázis · Ignis Therapeutics (Suzhou) Limited · Forrás
Lezárult
A Study to Assess the Efficacy and Safety of KarXT in Acutely Psychotic Hospitalized Chinese Adult Subjects With DSM-5 Schizophrenia
NCT05919823 · 3. fázis · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · Forrás
Lezárult
Effect of XingpiJieyu Formula on Mitochondrial Energy Metabolism in Severe Liver-Stagnation and Spleen-Deficiency Depression.
NCT07590609 · 4. fázis · Peking University Sixth Hospital · Forrás
Lezárult
Software-delivered CBT-I for Insomnia Disorder
NCT05747963 · Peking University Sixth Hospital · Forrás
Lezárult
A Study of Aticaprant 10 Milligrams (mg) as Adjunctive Therapy in Adult Participants With MDD With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy
NCT05550532 · 3. fázis · Janssen Research & Development, LLC · Forrás
Lezárult
Clinical Trial of Iclepertin Effect on Cognition and Functional Capacity in Schizophrenia (CONNEX-1)
NCT04846868 · 3. fázis · Boehringer Ingelheim · Forrás
Lezárult
A Study to Evaluate the Efficacy and Safety of Adjunctive Troriluzole in Obsessive-Compulsive Disorder
NCT04693351 · 3. fázis · Biohaven Pharmaceuticals, Inc. · Forrás
Lezárult
RCT Study on the Therapeutic Effect of Escitalopram Loaded With XingpiJieyu Formula on Resting State EEG Energy Abnormalities in Severe Liver Depression and Spleen Deficiency Type MDD
NCT06758167 · Peking University Sixth Hospital · Forrás
Lezárult
Effectiveness of eCBT-I on Improving Mental Health in Chinese Youths With Insomnia
NCT04069247 · Chinese University of Hong Kong · Forrás
Regiszterbeli névváltozatok (3) Mind mutatása Elrejtés A vizsgálati regiszterek ezeken a neveken tartják nyilván az intézményt. Minden sor egy regiszterbejegyzés: a címe és az alatta nyilvántartott vizsgálatok.
Peking University Sixth Hospital
Beijing, 100083
23 vizsgálat
Peking University Sixth Hospital
Haidian District, 100191
3 vizsgálat
Institute of Mental Health, Peking University Sixth Hospital
Beijing
1 vizsgálat
Betegségek Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.
Hibát jelzek